CHAPLIN DAVID

Director at Oncotelic Therapeutics, Inc. · on record since Feb 6, 2007
Chief Scientific Officer at Oncotelic Therapeutics, Inc. · on record since May 29, 2015

Insider trading activity of CHAPLIN DAVID

Transactions on record: 19; since Feb 17, 2004

Open-market buys: 4; $14.9K

Open-market sells: 0

Companies traded: 1; last filing Jun 22, 2018

Figures computed from official regulatory filings — .

Companies where CHAPLIN DAVID has traded

Oncotelic Therapeutics, Inc.19 tx · $114.7K · Jun 22, 2018

Track record of CHAPLIN DAVID

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of CHAPLIN DAVID

Co-insiders of CHAPLIN DAVID

Chin RichardOncotelic Therapeutics, Inc.
CITRON JOEL TOMASOncotelic Therapeutics, Inc.
DIAMOND DAVIDOncotelic Therapeutics, Inc.
DRISCOLL FREDERICK WOncotelic Therapeutics, Inc.
Fein Seymour HowardOncotelic Therapeutics, Inc.
FICKLING ROY HOncotelic Therapeutics, Inc.
Ha PamelaOncotelic Therapeutics, Inc.
Harris PeterOncotelic Therapeutics, Inc.
HOWSON TAMAR DOncotelic Therapeutics, Inc.
Hsiao ChaoOncotelic Therapeutics, Inc.
Hwang LarnOncotelic Therapeutics, Inc.
Johnson David LouisOncotelic Therapeutics, Inc.
KESSEL MARKOncotelic Therapeutics, Inc.
KING STEVEN WOncotelic Therapeutics, Inc.
Kollins John AOncotelic Therapeutics, Inc.
LAFFER ARTHUR BOncotelic Therapeutics, Inc.
LANGECKER PETEROncotelic Therapeutics, Inc.
LINDAHL STENOncotelic Therapeutics, Inc.
LOAR MATTHEW MOncotelic Therapeutics, Inc.
MAIDA ANTHONY E IIIOncotelic Therapeutics, Inc.
McMahon Gerald PhDOncotelic Therapeutics, Inc.
MURPHY JAMES BOncotelic Therapeutics, Inc.
Park ChulhoOncotelic Therapeutics, Inc.
Pedder SimonOncotelic Therapeutics, Inc.
Reynolds Donald RogersOncotelic Therapeutics, Inc.
RICHING BARBARAOncotelic Therapeutics, Inc.
SANDAGE BOBBY W PHDOncotelic Therapeutics, Inc.
Saund SaranOncotelic Therapeutics, Inc.
Schwieterman William DOncotelic Therapeutics, Inc.
Shah Amit B.Oncotelic Therapeutics, Inc.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Oncotelic Therapeutics, Inc.Listing on record	Jun 22, 2018	AwardD (derivative)	258,171	0.00 USD	—	SEC
Oncotelic Therapeutics, Inc.Listing on record	Jan 13, 2017	AwardD (derivative)	262,500	0.38 USD	$99.8K	SEC
Oncotelic Therapeutics, Inc.Listing on record	Mar 23, 2016	AwardD (derivative)	262,500	0.00 USD	—	SEC
Oncotelic Therapeutics, Inc.Listing on record	May 29, 2015	AwardD (derivative)	225,000	0.00 USD	—	SEC
Oncotelic Therapeutics, Inc.Listing on record	May 19, 2014	AwardD (derivative)	150,000	0.00 USD	—	SEC
Oncotelic Therapeutics, Inc.Listing on record	Jan 6, 2014	AwardD (derivative)	4,880	0.00 USD	—	SEC
Oncotelic Therapeutics, Inc.Listing on record	Jul 2, 2013	AwardD (derivative)	10,060	0.00 USD	—	SEC
Oncotelic Therapeutics, Inc.Listing on record	Jan 24, 2013	AwardD (derivative)	6,260	0.00 USD	—	SEC
Oncotelic Therapeutics, Inc.Listing on record	Sep 17, 2010	AwardD (derivative)	200,000	0.00	—	SEC
Oncotelic Therapeutics, Inc.Listing on record	Apr 29, 2010	AwardD (derivative)	400,000	0.00	—	SEC
Oncotelic Therapeutics, Inc.Listing on record	Jan 22, 2009	AwardD (derivative)	120,000	0.00	—	SEC
Oncotelic Therapeutics, Inc.Listing on record	Feb 6, 2007	AwardD (derivative)	25,000	0.00	—	SEC
Oncotelic Therapeutics, Inc.Listing on record	Oct 5, 2005	Award	80,000	0.00 USD	—	SEC
Oncotelic Therapeutics, Inc.Listing on record	Sep 2, 2004	AwardD (derivative)	50,000	0.00 USD	—	SEC
Oncotelic Therapeutics, Inc.Listing on record	May 21, 2004	Buy	100	7.38 USD	$738	SEC
Oncotelic Therapeutics, Inc.Listing on record	May 21, 2004	Buy	200	7.47 USD	$1.5K	SEC
Oncotelic Therapeutics, Inc.Listing on record	May 21, 2004	Buy	1,500	7.46 USD	$11.2K	SEC
Oncotelic Therapeutics, Inc.Listing on record	May 21, 2004	Buy	200	7.45 USD	$1.5K	SEC
Oncotelic Therapeutics, Inc.Listing on record	Feb 17, 2004	AwardD (derivative)	100,000	0.00 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Oncotelic Therapeutics, Inc.Listing on record	Jun 22, 2018	AwardD (derivative)	258,171	0.00 USD	—	SEC
Oncotelic Therapeutics, Inc.Listing on record	Jan 13, 2017	AwardD (derivative)	262,500	0.38 USD	$99.8K	SEC
Oncotelic Therapeutics, Inc.Listing on record	Mar 23, 2016	AwardD (derivative)	262,500	0.00 USD	—	SEC
Oncotelic Therapeutics, Inc.Listing on record	May 29, 2015	AwardD (derivative)	225,000	0.00 USD	—	SEC
Oncotelic Therapeutics, Inc.Listing on record	May 19, 2014	AwardD (derivative)	150,000	0.00 USD	—	SEC
Oncotelic Therapeutics, Inc.Listing on record	Jan 6, 2014	AwardD (derivative)	4,880	0.00 USD	—	SEC
Oncotelic Therapeutics, Inc.Listing on record	Jul 2, 2013	AwardD (derivative)	10,060	0.00 USD	—	SEC
Oncotelic Therapeutics, Inc.Listing on record	Jan 24, 2013	AwardD (derivative)	6,260	0.00 USD	—	SEC
Oncotelic Therapeutics, Inc.Listing on record	Sep 17, 2010	AwardD (derivative)	200,000	0.00	—	SEC
Oncotelic Therapeutics, Inc.Listing on record	Apr 29, 2010	AwardD (derivative)	400,000	0.00	—	SEC
Oncotelic Therapeutics, Inc.Listing on record	Jan 22, 2009	AwardD (derivative)	120,000	0.00	—	SEC
Oncotelic Therapeutics, Inc.Listing on record	Feb 6, 2007	AwardD (derivative)	25,000	0.00	—	SEC
Oncotelic Therapeutics, Inc.Listing on record	Oct 5, 2005	Award	80,000	0.00 USD	—	SEC
Oncotelic Therapeutics, Inc.Listing on record	Sep 2, 2004	AwardD (derivative)	50,000	0.00 USD	—	SEC
Oncotelic Therapeutics, Inc.Listing on record	May 21, 2004	Buy	100	7.38 USD	$738	SEC
Oncotelic Therapeutics, Inc.Listing on record	May 21, 2004	Buy	200	7.47 USD	$1.5K	SEC
Oncotelic Therapeutics, Inc.Listing on record	May 21, 2004	Buy	1,500	7.46 USD	$11.2K	SEC
Oncotelic Therapeutics, Inc.Listing on record	May 21, 2004	Buy	200	7.45 USD	$1.5K	SEC
Oncotelic Therapeutics, Inc.Listing on record	Feb 17, 2004	AwardD (derivative)	100,000	0.00 USD	—	SEC